Ausgabe 3/2019
Inhalt (27 Artikel)
Resistance to endocrine therapy in breast cancer: molecular mechanisms and future goals
Małgorzata Szostakowska, Alicja Trębińska-Stryjewska, Ewa Anna Grzybowska, Anna Fabisiewicz
A systematic review of interventions to improve adherence to endocrine therapy
Sue P. Heiney, Pearman D. Parker, Tisha M. Felder, Swann Arp Adams, Omonefe O. Omofuma, Jennifer M Hulett
Quantitative comparison of drug efficacy in treating hot flashes in patients with breast cancer
Ting Li, Juan Yang, Yinghua Lv, Fang Yin, Ling Xu, Hongxia Liu, Qingshan Zheng, Lujin Li
CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines
Britt I. Drögemöller, Galen E. B. Wright, Joanne Shih, Jose G. Monzon, Karen A. Gelmon, Colin J. D. Ross, Ursula Amstutz, Bruce C. Carleton, Wan C. Chang, Mary B. Connolly, Francois Dionne, Gabriella Groeneweg, Catrina M. Loucks, Stuart M. MacLeod, Sheila Pritchard, Shahrad R. Rassekh, Shubhayan Sanatani, Reo Tanoshima, Sean A. Virani, José G. Monzon, Amit P. Bhavsar, Michael J. Rieder, Neil H. Shear, Geoffrey Liu, Philip Khayat, Daniel Bernstein, Lawrence J. Lesko, Folefac Aminkeng
PAM50 for prediction of response to neoadjuvant chemotherapy for ER-positive breast cancer
Ako Matsushita Ohara, Yasuto Naoi, Kenzo Shimazu, Naofumi Kagara, Masafumi Shimoda, Tomonori Tanei, Tomohiro Miyake, Seung Jin Kim, Shinzaburo Noguchi
The flaxseed lignan secoisolariciresinol diglucoside decreases local inflammation, suppresses NFκB signaling, and inhibits mammary tumor growth
Laura W. Bowers, Claire G. Lineberger, Nikki A. Ford, Emily L. Rossi, Arunima Punjala, Kristina K. Camp, Bruce K. Kimler, Carol J. Fabian, Stephen D. Hursting
Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle intervention
Katherine R. Walter, Marvella E. Ford, Mathew J. Gregoski, Rita M. Kramer, Kendrea D. Knight, Laura Spruill, Lourdes M. Nogueira, Bradley A. Krisanits, Van Phan, Amanda C. La Rue, Michael B. Lilly, Stefan Ambs, King Chan, Tonya F. Turner, Heidi Varner, Shweta Singh, Jaime Uribarri, Elizabeth Garrett-Mayer, Kent E. Armeson, Ebony J. Hilton, Mark J. Clair, Marian H. Taylor, Andrea M. Abbott, Victoria J. Findlay, Lindsay L. Peterson, Gayenell Magwood, David P. Turner
Combinatorial expression of microtubule-associated EB1 and ATIP3 biomarkers improves breast cancer prognosis
Sylvie Rodrigues-Ferreira, Anne Nehlig, Clarisse Monchecourt, Sarah Nasr, Laetitia Fuhrmann, Magali Lacroix-Triki, Ingrid Garberis, Véronique Scott, Suzette Delaloge, Barbara Pistilli, Philippe Vielh, Thierry Dubois, Anne Vincent-Salomon, Fabrice André, Clara Nahmias
Rationally derived drug combinations with the novel Mcl-1 inhibitor EU-5346 in breast cancer
Sonia Vallet, Fengjuan Fan, Stefano Malvestiti, Martin Pecherstorfer, Martin Sattler, Andreas Schneeweiss, Henning Schulze-Bergkamen, Joseph T. Opferman, Michael H. Cardone, Dirk Jäger, Klaus Podar
Racial disparities in breast cancer persist despite early detection: analysis of treatment of stage 1 breast cancer and effect of insurance status on disparities
Ethan J. Hoppe, Lala R. Hussain, Kevin J. Grannan, Erik M. Dunki-Jacobs, David Y. Lee, Barbara A. Wexelman
Treatment delays from transfers of care and their impact on breast cancer quality measures
Richard J. Bleicher, Cecilia Chang, Chihsiung E. Wang, Lori J. Goldstein, Cary S. Kaufmann, Meena S. Moran, Karen A. Pollitt, Nicholas R. Suss, David P. Winchester, Lorraine Tafra, Katharine Yao
Pretreatment anti-Mullerian hormone-based nomogram predicts menstruation status after chemotherapy for premenopausal women with hormone receptor-positive early breast cancer
Cong Xue, Wenwen Wei, Peng Sun, Wei Zheng, Xiaoju Diao, Fei Xu, Jiajia Huang, Xin An, Wen Xia, Ruoxi Hong, Kuikui Jiang, Riqing Huang, Zhongyu Yuan, Shusen Wang, Anhua Li, Ruhai Zou, Yanxia Shi
YouTube English videos as a source of information on breast self-examination
Ebru Esen, Mehmet Aslan, Bilgehan Çağdaş Sonbahar, Ramazan Saygın Kerimoğlu
Type 2 diabetes as a predictor of survival among breast cancer patients: the multiethnic cohort
Gertraud Maskarinec, Yurii B. Shvetsov, Shannon M. Conroy, Christopher A. Haiman, Veronica W. Setiawan, Loïc Le Marchand
Adult weight change and the risk of pre- and postmenopausal breast cancer in the Chinese Wuxi Exposure and Breast Cancer Study
Shang Cao, Jinyi Zhou, Zheng Zhu, Feiran Wei, Wei Li, Shurong Lu, Jian Su, Hao Yu, Wencong Du, Lan Cui, Pingmin Wei, Ming Wu
Age-related risk factors associated with primary contralateral breast cancer among younger women versus older women
Tae In Yoon, Beom Seok Kwak, On Vox Yi, Seonok Kim, Eunhae Um, Keong Won Yun, Hae-na Shin, SaeByul Lee, Guiyun Sohn, Il Yong Chung, Jisun Kim, Beom Seok Ko, Jong Won Lee, Byung Ho Son, Sei Hyun Ahn, Hee Jeong Kim
Molecular mechanisms linking high body mass index to breast cancer etiology in post-menopausal breast tumor and tumor-adjacent tissues
Yujing J. Heng, Jun Wang, Thomas U. Ahearn, Susan B. Brown, Xuehong Zhang, Christine B. Ambrosone, Victor Piana de Andrade, Adam M. Brufsky, Fergus J. Couch, Tari A. King, Francesmary Modugno, Celine M. Vachon, Natalie C. DuPre, Montserrat Garcia-Closas, Melissa A. Troester, David J. Hunter, A. Heather Eliassen, Rulla M. Tamimi, Susan E. Hankinson, Andrew H. Beck
Clinical subtypes and prognosis in breast cancer according to parity: a nationwide study in Korean Breast Cancer Society
Sungmin Park, Byung In Moon, Se Jeong Oh, Han-Byoel Lee, Min-Ki Seong, Seokwon Lee, Kyung Do Byun, Seung Pil Jung, Soo Youn Bae
Racial/ethnic disparities in inflammatory breast cancer survival in the Michigan Cancer Surveillance Program
Abdi T. Gudina, Glenn Copeland, Amr S. Soliman, Kelly A. Hirko
Survivorship care visits in a high-risk population of breast cancer survivors
Sarah J. Skuli, Jennifer Y. Sheng, Elissa T. Bantug, Nelli Zafman, Carol Riley, Jessica M. Ruck, Katherine C. Smith, Claire F. Snyder, Karen L. Smith, Vered Stearns, Antonio C. Wolff
Impact of pre-diagnosis depressive symptoms and health-related quality of life on treatment choice for ductal carcinoma in situ and stage I breast cancer in older women
Daniela L. Buscariollo, Angel M. Cronin, Nancy A. Borstelmann, Rinaa S. Punglia
Concordance with BRCA1/2 testing guidelines among women in The Health of Women (HOW) Study®
Michelle I. Silver, William Klein, Goli Samimi, Lori Minasian, Jennifer Loud, Megan C. Roberts
The intron 3 16 bp duplication polymorphism of p53 (rs17878362) is not associated with increased risk of developing triple-negative breast cancer
Brianna C. Morten, Simon Chiu, Christopher Oldmeadow, Jan Lubinski, Rodney J. Scott, Kelly A. Avery-Kiejda
Predictive value of lymphoscintigraphy in patients with breast cancer-related lymphedema undergoing complex decongestive therapy
Young Hwan Kim, Ji Hye Hwang, Ji Hoon Bae, Joon Young Choi
Trends in stage at diagnosis for young breast cancer patients in the United States
Carol E. DeSantis, Jiemin Ma, Ahmedin Jemal
Association between pre-operative magnetic resonance imaging (MRI) and surgical outcomes in breast cancer: not yet determined
Ran Xu, Peipei Tang, Chunmei Li
Clinical implication of E-cadherin deficiency in lobular breast cancer
Giovanni Corso, Gabriella Pravettoni, Viviana Galimberti, Paolo Veronesi